Thus, the present study evaluated the antitumor potential ofBthTX-I against MCF7, SKBR3, and MDAMB231 cell lines, which represent the luminal,HER-2-enriched, and triple-negative breast carcinoma subtypes, respectively. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.